Covira
Jeff McCown is a seasoned business executive with extensive experience in the biotech and healthcare sectors. Currently serving as a Business Development Executive at Three Squared Biosciences, Covira, and Gateway Biome since 2023, Jeff focuses on leveraging gut microbiome science to develop innovative diagnostic and therapeutic products. Jeff also plays an advisory role at Tiny Bubbles OKC, contributing to the company's expansion into a wine bar. Previous experience includes serving as Executive Director of Sales and Marketing at the Diagnostic Laboratory of Oklahoma, Senior Sales Director at WMS Gaming, and Sales Director for Abbott, where responsibilities encompassed business growth and employee development. Jeff holds a BS in Business Administration from Oklahoma State University.
This person is not in any teams
This person is not in any offices
Covira
Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria. It is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira’s platform technology generated a lead asset (CS-0003) that modulates bacterialvirulence and restores microbial communities to prevent post-surgical infection. Covira’s approach is transformative to the field and the world is taking notice...in the 4th quarter of last year, Business Worldwide Magazine named Covira Among the 2021 - Top 20 Most Innovative Companies to Watch.